Gordian Biotechnology Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
40
- Latest Deal Type
-
Later Stage VC
- Investors
-
30
Gordian Biotechnology General Information
Description
Developer of a gene therapy discovery platform designed to improve research for complex diseases related to aging. The company's platform researches and develops therapeutic drugs that can prevent premature aging in humans, enabling doctors to cure age-related diseases and patients to improve their skin conditions.
Contact Information
Website
www.gordian.bioCorporate Office
- 486 Cabot Road
- Gordian Biotechnology
- South San Francisco, CA 94080
- United States
Corporate Office
- 486 Cabot Road
- Gordian Biotechnology
- South San Francisco, CA 94080
- United States
Gordian Biotechnology Timeline
Gordian Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 01-Jun-2025 | Completed | Product Development | |||
| 7. Accelerator/Incubator | 29-Apr-2025 | Completed | Product Development | |||
| 6. Later Stage VC | 26-Apr-2024 | Completed | Product Development | |||
| 5. Secondary Transaction - Private | Completed | Product Development | ||||
| 4. Early Stage VC (Series A) | 10-Dec-2021 | Completed | Product Development | |||
| 3. Seed Round | 21-Apr-2020 | Completed | Product Development | |||
| 2. Accelerator/Incubator | 01-Jan-2019 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
Gordian Biotechnology Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-4 | ||||||||
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Seed-2 | ||||||||
| Seed-1 | 183,297 | $0.000010 | 6% | $0.74 | $0.74 | 1x | $0.74 | 0.65% |
| Seed | 4,011,137 | $0.000010 | 6% | $1.02 | $1.02 | 1x | $1.02 | 14.29% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Gordian Biotechnology Patents
Gordian Biotechnology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026187921-A1 | Serpina1 methods and compositions | Pending | 04-Mar-2025 | ||
| EP-4330400-A1 | Compositions and methods for in vivo screening of therapeutics | Pending | 26-Apr-2021 | ||
| EP-4330400-A4 | Compositions and methods for in vivo screening of therapeutics | Pending | 26-Apr-2021 | ||
| US-20240200229-A1 | Compositions and methods for in vivo screening of therapeutics | Pending | 26-Apr-2021 | ||
| WO-2022232054-A1 | Compositions and methods for in vivo screening of therapeutics | Inactive | 26-Apr-2021 | C12Q1/6897 |
Gordian Biotechnology Signals
Gordian Biotechnology Investors (30)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| K5 Global | Venture Capital | Minority | ||
| Starbloom Capital | Venture Capital | Minority | ||
| Charles River Incubator Program | Accelerator/Incubator | |||
| Arctic Ventures | Venture Capital | Minority | ||
| Athos Service | Family Office | Minority |
Gordian Biotechnology FAQs
-
When was Gordian Biotechnology founded?
Gordian Biotechnology was founded in 2018.
-
Where is Gordian Biotechnology headquartered?
Gordian Biotechnology is headquartered in South San Francisco, CA.
-
What is the size of Gordian Biotechnology?
Gordian Biotechnology has 40 total employees.
-
What industry is Gordian Biotechnology in?
Gordian Biotechnology’s primary industry is Drug Discovery.
-
Is Gordian Biotechnology a private or public company?
Gordian Biotechnology is a Private company.
-
What is Gordian Biotechnology’s current revenue?
The current revenue for Gordian Biotechnology is .
-
How much funding has Gordian Biotechnology raised over time?
Gordian Biotechnology has raised $60M.
-
Who are Gordian Biotechnology’s investors?
K5 Global, Starbloom Capital, Charles River Incubator Program, Arctic Ventures, and Athos Service are 5 of 30 investors who have invested in Gordian Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process